机译:溶瘤病毒疗法促进肿瘤内渗透并改善抗PD-1免疫疗法
Univ Calif Los Angeles Johnsson Comprehens Canc Ctr Los Angeles CA 90095 USA;
Univ Hosp Zurich Zurich Switzerland;
Roswell Pk Canc Inst Buffalo NY 14263 USA;
West Clin Memphis TN USA;
Univ Utah Huntsman Canc Inst Salt Lake City UT USA;
CHU Vaudois Lausanne Switzerland;
Fox Chase Canc Ctr 7701 Burholme Ave Philadelphia PA 19111 USA;
Hosp Clin Barcelona Barcelona Spain;
La Trobe Univ Olivia Newton John Canc Res Inst Austin Hlth Sch Canc Med Heidelberg Vic Australia;
Hop Univ Geneve Geneva Switzerland;
Univ Pittsburgh Inst Canc Pittsburgh PA USA;
Univ Chicago Sch Med Chicago IL 60637 USA;
Amgen Inc Thousand Oaks CA 91320 USA;
Amgen Inc San Francisco CA USA;
Amgen Inc Thousand Oaks CA 91320 USA;
Merck &
Co Inc Kenilworth NJ USA;
Merck &
Co Inc Kenilworth NJ USA;
Amgen Inc Thousand Oaks CA 91320 USA;
Dana Farber Canc Inst Boston MA 02115 USA;
Univ Sydney Melanoma Inst Australia Sydney NSW Australia;
机译:溶瘤病毒促进肿瘤患者渗透,改善抗PD-1免疫疗法(Vol 170,1109.e1,2017)
机译:VEGF阻断部分通过调节肿瘤内髓样细胞使溶瘤癌病毒治疗成为可能
机译:Neoadjuvant Anti-PD-1免疫疗法促进了复发性胶质母细胞瘤中的肿瘤内和全身免疫应答的生存益处
机译:矢量化在抗体抗体的抗体疫苗病毒中,针对编程的细胞死亡-1(PD-1)允许其肿瘤内递送和改善的肿瘤生长抑制
机译:Necroptosis:在痘病毒发病机制和溶瘤病毒治疗中的作用
机译:对Zhou等人的支持信息的校正全氟化碳纳米粒子介导的血小板抑制促进T细胞的肿瘤渗透并提高免疫疗法
机译:溶瘤病毒疗法促进肿瘤内渗透并改善抗PD-1免疫疗法